XNCR Q4 2017 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$861M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+69.9% YoY

Gross Profit

$11M100.0% margin

Operating Income

-$14M-126.9% margin

Net Income

-$12M-108.2% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+54.3%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$390M

Total Liabilities

$108M

Stockholders' Equity

$282M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$6M	+69.9%
Gross Profit	$11M	-$7M	+258.1%
Operating Income	-$14M	-$10M	-38.4%
Net Income	-$12M	-$9M	-30.6%